PlainRecalls
FDA Drug Low Class III Terminated

Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01

Reported: September 26, 2018 Initiated: August 23, 2018 #D-1214-2018

Product Description

Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01

Reason for Recall

Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.

Details

Recalling Firm
LUPIN SOMERSET
Units Affected
4716 bottle
Distribution
U.S.A. Nationwide
Location
Somerset, NJ

Frequently Asked Questions

What product was recalled?
Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01. Recalled by LUPIN SOMERSET. Units affected: 4716 bottle.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 26, 2018. Severity: Low. Recall number: D-1214-2018.